• About us
• Contact

Advertisement

Document › Details

Fluidigm Corporation. (5/7/20). "Press Release: Fluidigm Announces First Quarter 2020 Financial Results". South San Francisco, CA.

	Organisation	Fluidigm Corporation (Nasdaq: FLDM)
	Group	Fluidigm (Group)
	Organisation 2	BioXpedia A/S
	Product	BioMark™ Real-time PCR system

Record changed: 2023-06-05

Advertisement

More documents for Fluidigm (Group)

• [1] Fluidigm Corporation. (5/7/20). "Press Release: Fluidigm Expands Accessibility of Mass Cytometry and Imaging Mass Cytometry Technology with New Therapeutic Insights Services". South San Francisco, CA....
• [2] Fluidigm Corporation. (3/3/20). "Press Release: Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing". South San Francisco, CA & Hinxton....
• [3] Fluidigm Corporation. (2/26/20). "Press Release: Fluidigm Completes Acquisition of InstruNor AS". South San Francisco, CA....
• [4] Fluidigm Corporation. (2/10/20). "Press Release: Fluidigm CyTOF Technology Selected by Covance to Develop Highly Multiplexed Human Immune Profiling Services". South San Francisco, CA....
• [5] Fluidigm Corporation. (2/10/20). "Press Release: Fluidigm Announces Fourth Quarter and Full Year 2019 Financial Results". South San Francisco, CA....
• [6] MorphoSys AG. (11/20/19). "Press Release: Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure". Planegg....
• [7] Fluidigm Corporation. (5/29/19). "Press Release: Fluidigm Introduces Automated Advanta Solid Tumor NGS Library Prep Assay Using Microfluidics Technology". South San Francisco, CA....
• [8] Fluidigm Corporation. (5/2/19). "Press Release: Fluidigm Announces First Quarter 2019 Financial Results". South San Francisco, CA....
• [9] Fluidigm Corporation. (3/5/19). "Press Release: Colin McCracken Joins Fluidigm as Chief Commercial Officer". South San Francisco, CA....
• [10] Fluidigm Corporation. (2/7/19). "Press Release: Fluidigm Announces Participation in Life Science/Pharma and Academic Consortium to Study T Cell-Driven Immune-Mediated Inflammatory Diseases". South San Francisco, CA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.